Clinical Liver Disease
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 111:15:50
- Mais informações
Informações:
Sinopse
Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.
Episódios
-
![Rationing Care: Barriers to Direct‐Acting Antiviral Treatment in Medicaid Treatment Criteria]()
Rationing Care: Barriers to Direct‐Acting Antiviral Treatment in Medicaid Treatment Criteria
07/06/2019 Duração: 09minAudible Article by Phil Waters and Tina Broder
-
![Assessment and Management of Nutrition Status in the Hospitalized Patient With Cirrhosis]()
Assessment and Management of Nutrition Status in the Hospitalized Patient With Cirrhosis
07/06/2019 Duração: 09minAudible Article by Christopher Moore and Adam C. Stein
-
![At Diagnosis of Hepatocellular Carcinoma, African Americans With Hepatitis C Have Better Liver Function Than Other Patients]()
At Diagnosis of Hepatocellular Carcinoma, African Americans With Hepatitis C Have Better Liver Function Than Other Patients
07/06/2019 Duração: 09minAudible Article by Adam C. Winters, Julie C. Sung, Brooke Wyatt, Deeva Berera, Thomas D. Schiano, Myron E. Schwartz, Ponni V. Perumalswami, and Andrea D. Branch
-
![Con: Use of Hepatitis C Virus–Positive Donors Should Be Restricted to Research Protocols]()
Con: Use of Hepatitis C Virus–Positive Donors Should Be Restricted to Research Protocols
07/06/2019 Duração: 09minAudible Article by Grace S. Lee, Judith A. Anesi, Behdad D. Besharatian, Therese Bittermann, Stephanie Hamel, and David S. Goldberg
-
![Pro: Use of Hepatitis C Virus–Positive Donors Should Be Considered Standard of Care]()
Pro: Use of Hepatitis C Virus–Positive Donors Should Be Considered Standard of Care
07/06/2019 Duração: 09minAudible Article by William A. Werbel and Christine M. Durand
-
![Misconception: You Can’t Have Liver Disease With Normal Liver Chemistrie]()
Misconception: You Can’t Have Liver Disease With Normal Liver Chemistrie
07/06/2019 Duração: 09minAudible Article by Zurabi Lominadze and Eric R. Kallwitz
-
![Spotlight on Impactful Research: Evaluation of Hepatitis B Reactivation Among 62,920 Veterans Treated With Oral Hepatitis C Antivirals]()
Spotlight on Impactful Research: Evaluation of Hepatitis B Reactivation Among 62,920 Veterans Treated With Oral Hepatitis C Antivirals
07/06/2019 Duração: 09minAudible Article by Mina Rakoski
-
![Risk of Nonsteroidal Anti‐inflammatory Drugs and Safety of Acetaminophen in Patients with Advanced Liver Disease]()
Risk of Nonsteroidal Anti‐inflammatory Drugs and Safety of Acetaminophen in Patients with Advanced Liver Disease
07/06/2019 Duração: 09minAudible Article by Miguel H. Malespin
-
![Paracentesis Model for Junior Doctors]()
Paracentesis Model for Junior Doctors
07/06/2019 Duração: 09minAudible Article by Jemma Mildon, Johann Willers, and Sam J. Thomson
-
![Spotlight on Impactful Research: Universal Screening for Alcohol Misuse in Acute Admissions Is Feasible and Identifies Patients at High Risk for Liver Disease]()
Spotlight on Impactful Research: Universal Screening for Alcohol Misuse in Acute Admissions Is Feasible and Identifies Patients at High Risk for Liver Disease
07/06/2019 Duração: 09minAudible Article by Jessica L. Mellinger
-
![Primer on Percutaneous Ablation of Benign Liver Tumors]()
Primer on Percutaneous Ablation of Benign Liver Tumors
07/06/2019 Duração: 09minAudible Article by Shane A. Wells, Timothy J. Ziemlewicz, and Meghan G. Lubner
-
![PRO: Patients With Advanced Cirrhosis and Portal Vein Thrombosis Should Receive Anticoagulation]()
PRO: Patients With Advanced Cirrhosis and Portal Vein Thrombosis Should Receive Anticoagulation
07/06/2019 Duração: 09minAudible Article by Uyen Kim To and Guadalupe Garcia‐Tsao
-
![CON: Anticoagulation for Portal Vein Thrombosis in Advanced Cirrhosis]()
CON: Anticoagulation for Portal Vein Thrombosis in Advanced Cirrhosis
07/06/2019 Duração: 09minAudible Article by Kevin M. Rank and John Lake
-
![Spotlight on Impactful Research: Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systemic Review and Meta‐Analysis]()
Spotlight on Impactful Research: Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systemic Review and Meta‐Analysis
07/06/2019 Duração: 09minAudible Article by Natasha von Roenn
-
![Closing the Quality Chasm in Cirrhosis]()
Closing the Quality Chasm in Cirrhosis
07/06/2019 Duração: 09minAudible Article by Kai Rou Tey, Prashanthinie Mohan, Xibei Liu, and Archita P. Desai
-
![Pitfalls in Gd‐EOB‐DTPA–Enhanced Liver Magnetic Resonance Imaging With an Emphasis on Nontumorous Lesions]()
Pitfalls in Gd‐EOB‐DTPA–Enhanced Liver Magnetic Resonance Imaging With an Emphasis on Nontumorous Lesions
07/06/2019 Duração: 09minAudible Article by Yedaun Lee, So Yeon Kim, Seung Soo Lee, Seong Ho Park, Kyoung Won Kim, Jae Ho Byun, and Moon‐Gyu Lee
-
![The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes]()
The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes
07/06/2019 Duração: 09minAudible Article by Carrie R. Wong and Joseph K. Lim
-
![PRO: Redistricting of United Network for Organ Sharing Regions to Improve Geographic Disparities in Liver Transplantation]()
PRO: Redistricting of United Network for Organ Sharing Regions to Improve Geographic Disparities in Liver Transplantation
07/06/2019 Duração: 09minAudible Article by Fernando H. Calmet, Maria Samuel, and Paul Martin
-
![Hepatitis B: Standard and Novel Treatment Options]()
Hepatitis B: Standard and Novel Treatment Options
07/06/2019 Duração: 09minAudible Article by Joseph C. Ahn
-
![Disease Pathways and Mechanisms of Potential Drug Targets]()
Disease Pathways and Mechanisms of Potential Drug Targets
07/06/2019 Duração: 09minAudible Article by Marc G. Ghany and Timothy M. Block
